Results 131 to 140 of about 15,888 (236)

Vasoactive intestinal peptide receptor scintigraphy

open access: yesBiomedicine & Pharmacotherapy, 1996
I. Virgolini   +7 more
openaire   +1 more source

Analysis of airway secretions in a model of sulfur dioxide induced chronic obstructive pulmonary disease (COPD)

open access: yes, 2006
Hypersecretion and chronic phlegm are major symptoms of chronic obstructive pulmonary disease (COPD) but animal models of COPD with a defined functional hypersecretion have not been established so far.
David A Groneberg   +17 more
core   +1 more source

Vasoactive intestinal peptide (VIP) induces transactivation of EGFR and HER2 in human breast cancer cells

open access: yes, 2009
We analyzed the cross-talk between receptors for vasoactive intestinal peptide (VIP) and the human epidermal growth factor family of tyrosine kinase receptors (HER) in oestrogen-dependent (T47D) and oestrogen-independent (MDA-MB-468) human breast cancer ...
Schally, Andrew V   +5 more
core   +1 more source

Vasoactive Intestinal Peptide (VIP)1 Receptor

open access: yesJournal of Biological Chemistry, 1996
Alain Couvineau   +5 more
openaire   +1 more source

Effect of Intracavernous Simultaneous Injection of Acetylcholine and VIP on Canine Penile Erection [PDF]

open access: yes, 1992
Lue, Tom F.   +5 more
core  

Expression and localization of VPAC1, the major receptor of vasoactive intestinal peptide along the length of the intestine.

open access: yes, 2018
Vasoactive intestinal peptide (VIP) is an endogenous neuropeptide with a broad array of physiological functions in many organs including the intestine. Its actions are mediated via G protein-coupled receptors, and vasoactive intestinal peptide receptor 1
Pradeep K. Dudeja (7929041)   +5 more
core  

Home - About - Disclaimer - Privacy